Cargando…
Anti-HSV-1 activity of Aspergillipeptide D, a cyclic pentapepetide isolated from fungus Aspergillus sp. SCSIO 41501
BACKGROUND: Herpes simplex virus 1, an enveloped DNA virus belonging to the Herpesviridae family, spreads to neurons and causes pathological changes in the central nervous system. The purpose of this study was to investigate the potency and mechanism of antiviral activity of Aspergillipeptide D, a c...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081692/ https://www.ncbi.nlm.nih.gov/pubmed/32192525 http://dx.doi.org/10.1186/s12985-020-01315-z |
_version_ | 1783508223015256064 |
---|---|
author | Wang, Zhaoyang Jia, Jiaoyan Wang, Lu Li, Feng Wang, Yiliang Jiang, Yuzhou Song, Xiaowei Qin, Shurong Zheng, Kai Ye, Ju Ren, Zhe Wang, Yifei Qi, Shuhua |
author_facet | Wang, Zhaoyang Jia, Jiaoyan Wang, Lu Li, Feng Wang, Yiliang Jiang, Yuzhou Song, Xiaowei Qin, Shurong Zheng, Kai Ye, Ju Ren, Zhe Wang, Yifei Qi, Shuhua |
author_sort | Wang, Zhaoyang |
collection | PubMed |
description | BACKGROUND: Herpes simplex virus 1, an enveloped DNA virus belonging to the Herpesviridae family, spreads to neurons and causes pathological changes in the central nervous system. The purpose of this study was to investigate the potency and mechanism of antiviral activity of Aspergillipeptide D, a cyclic pentapeptide isolated from a culture broth of marine gorgonian-derived fungus Aspergillus sp. SCSIO 41501, At present, there are many studies on the anti-tumor, anti-clotting, anti-oxidant and immunoinflammatory effects of Aspergillipeptide D, but little research has been done on the anti-HSV-1 activity of Aspergillipeptide D. METHODS: The anti-HSV-1 activity of Aspergillipeptide D was evaluated by plaque reduction assay. The mechanism of action against HSV-1 was determined from the effective stage. Then we assayed the viral DNA replication, viral RNA synthesis and protein expression, respectively. We also identified the proteins that interact with gB by mass spectrometry, and assayed the effect of Aspergillipeptide D on the interaction between the virus gB protein and cell proteins. RESULTS: Plaque reduction experiments showed that Aspergillipeptide D did not affect HSV-1 early infection events, including viral inactivation, attachment and penetration. Interestingly, Aspergillipeptide D dramatically reduced both the gene and protein levels of viral late protein gB, and suppressed its location in the endoplasmic reticulum and Golgi apparatus. In contrast, overexpression of gB restored viral production. Finally, proteomic analysis revealed that the numbers of cellular proteins that interacted with gB protein was largely decreased by Aspergillipeptide D. These results suggested that Aspergillipeptide D inhibited gB function to affect HSV-1 intercellular spread. CONCLUSIONS: Our results indicated that Aspergillipeptide D might be a potential candidate for HSV-1 therapy, especially for ACV-resistant strains. |
format | Online Article Text |
id | pubmed-7081692 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-70816922020-03-23 Anti-HSV-1 activity of Aspergillipeptide D, a cyclic pentapepetide isolated from fungus Aspergillus sp. SCSIO 41501 Wang, Zhaoyang Jia, Jiaoyan Wang, Lu Li, Feng Wang, Yiliang Jiang, Yuzhou Song, Xiaowei Qin, Shurong Zheng, Kai Ye, Ju Ren, Zhe Wang, Yifei Qi, Shuhua Virol J Research BACKGROUND: Herpes simplex virus 1, an enveloped DNA virus belonging to the Herpesviridae family, spreads to neurons and causes pathological changes in the central nervous system. The purpose of this study was to investigate the potency and mechanism of antiviral activity of Aspergillipeptide D, a cyclic pentapeptide isolated from a culture broth of marine gorgonian-derived fungus Aspergillus sp. SCSIO 41501, At present, there are many studies on the anti-tumor, anti-clotting, anti-oxidant and immunoinflammatory effects of Aspergillipeptide D, but little research has been done on the anti-HSV-1 activity of Aspergillipeptide D. METHODS: The anti-HSV-1 activity of Aspergillipeptide D was evaluated by plaque reduction assay. The mechanism of action against HSV-1 was determined from the effective stage. Then we assayed the viral DNA replication, viral RNA synthesis and protein expression, respectively. We also identified the proteins that interact with gB by mass spectrometry, and assayed the effect of Aspergillipeptide D on the interaction between the virus gB protein and cell proteins. RESULTS: Plaque reduction experiments showed that Aspergillipeptide D did not affect HSV-1 early infection events, including viral inactivation, attachment and penetration. Interestingly, Aspergillipeptide D dramatically reduced both the gene and protein levels of viral late protein gB, and suppressed its location in the endoplasmic reticulum and Golgi apparatus. In contrast, overexpression of gB restored viral production. Finally, proteomic analysis revealed that the numbers of cellular proteins that interacted with gB protein was largely decreased by Aspergillipeptide D. These results suggested that Aspergillipeptide D inhibited gB function to affect HSV-1 intercellular spread. CONCLUSIONS: Our results indicated that Aspergillipeptide D might be a potential candidate for HSV-1 therapy, especially for ACV-resistant strains. BioMed Central 2020-03-19 /pmc/articles/PMC7081692/ /pubmed/32192525 http://dx.doi.org/10.1186/s12985-020-01315-z Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Wang, Zhaoyang Jia, Jiaoyan Wang, Lu Li, Feng Wang, Yiliang Jiang, Yuzhou Song, Xiaowei Qin, Shurong Zheng, Kai Ye, Ju Ren, Zhe Wang, Yifei Qi, Shuhua Anti-HSV-1 activity of Aspergillipeptide D, a cyclic pentapepetide isolated from fungus Aspergillus sp. SCSIO 41501 |
title | Anti-HSV-1 activity of Aspergillipeptide D, a cyclic pentapepetide isolated from fungus Aspergillus sp. SCSIO 41501 |
title_full | Anti-HSV-1 activity of Aspergillipeptide D, a cyclic pentapepetide isolated from fungus Aspergillus sp. SCSIO 41501 |
title_fullStr | Anti-HSV-1 activity of Aspergillipeptide D, a cyclic pentapepetide isolated from fungus Aspergillus sp. SCSIO 41501 |
title_full_unstemmed | Anti-HSV-1 activity of Aspergillipeptide D, a cyclic pentapepetide isolated from fungus Aspergillus sp. SCSIO 41501 |
title_short | Anti-HSV-1 activity of Aspergillipeptide D, a cyclic pentapepetide isolated from fungus Aspergillus sp. SCSIO 41501 |
title_sort | anti-hsv-1 activity of aspergillipeptide d, a cyclic pentapepetide isolated from fungus aspergillus sp. scsio 41501 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081692/ https://www.ncbi.nlm.nih.gov/pubmed/32192525 http://dx.doi.org/10.1186/s12985-020-01315-z |
work_keys_str_mv | AT wangzhaoyang antihsv1activityofaspergillipeptidedacyclicpentapepetideisolatedfromfungusaspergillusspscsio41501 AT jiajiaoyan antihsv1activityofaspergillipeptidedacyclicpentapepetideisolatedfromfungusaspergillusspscsio41501 AT wanglu antihsv1activityofaspergillipeptidedacyclicpentapepetideisolatedfromfungusaspergillusspscsio41501 AT lifeng antihsv1activityofaspergillipeptidedacyclicpentapepetideisolatedfromfungusaspergillusspscsio41501 AT wangyiliang antihsv1activityofaspergillipeptidedacyclicpentapepetideisolatedfromfungusaspergillusspscsio41501 AT jiangyuzhou antihsv1activityofaspergillipeptidedacyclicpentapepetideisolatedfromfungusaspergillusspscsio41501 AT songxiaowei antihsv1activityofaspergillipeptidedacyclicpentapepetideisolatedfromfungusaspergillusspscsio41501 AT qinshurong antihsv1activityofaspergillipeptidedacyclicpentapepetideisolatedfromfungusaspergillusspscsio41501 AT zhengkai antihsv1activityofaspergillipeptidedacyclicpentapepetideisolatedfromfungusaspergillusspscsio41501 AT yeju antihsv1activityofaspergillipeptidedacyclicpentapepetideisolatedfromfungusaspergillusspscsio41501 AT renzhe antihsv1activityofaspergillipeptidedacyclicpentapepetideisolatedfromfungusaspergillusspscsio41501 AT wangyifei antihsv1activityofaspergillipeptidedacyclicpentapepetideisolatedfromfungusaspergillusspscsio41501 AT qishuhua antihsv1activityofaspergillipeptidedacyclicpentapepetideisolatedfromfungusaspergillusspscsio41501 |